Fresenius | FRE - Ebitda

Preço das Ações
46.92
Mudança Diária
0.10 0.21%
Mensal
-9.98%
Anual
17.54%
Q1 Previsão
45.46




Ebitda Alterar Data
Akzo Nobel EUR 385M 8M 2025-09
Alcon AG USD 317M 337M 2025-12
AstraZeneca USD 5.23B 272M 2025-09
BASF EUR 1.54B 228M 2025-09
Bayer EUR 1.97B 457M 2025-12
Beiersdorf EUR 984M 147M 2025-06
DaVita Healthcare Partners USD 772.7M 89.45M 2025-12
Demant DKK 2.76B 165M 2025-12
E.ON EUR 1.78B 438M 2025-09
Essilor EUR 3.09B 356M 2024-12
Fresenius EUR 850M 22M 2025-09
Fresenius Medical Care EUR 1.07B 142.74M 2025-12
Getinge SEK 3.47B 2.13B 2024-12
Givaudan CHF 778M 195M 2025-12
GlaxoSmithKline GBP 3.36B 179M 2025-09
GN Store Nord DKK 627M 106M 2025-12
GRIFOLS EUR 347.24M 58.35M 2025-06
Hikma Pharmaceutical USD 369M 84M 2024-12
Lonza CHF 1.01B 54M 2025-12
Merck EUR 1.44B 263M 2025-12
Novartis USD 5.88B 290M 2025-09
Philips EUR 738M 9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
RWE EUR 1.61B 274M 2025-12
Sanofi EUR 4.84B 2.95B 2025-09
Smith & Nephew USD 796M 139M 2025-12